Ikapharmindo Putramas Tbk. vs Chandra Asri Pacific Tbk. — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 308.29B, 900 24h volume), while Chandra Asri Pacific Tbk. trades at Rp1,930 (market cap 165.24T, 202.97M 24h volume). The key difference: Chandra Asri Pacific Tbk. is far larger — about 536× Ikapharmindo Putramas Tbk.'s market cap, and Chandra Asri Pacific Tbk. is more actively traded (202.97M versus 900). Which is the better fit depends on your goals.
| IKPM | TPIA | |
|---|---|---|
Market Cap | 308.29B | 165.24T |
Volume | 900 | 202.97M |
Lot | 9 | 2.03M |
Turnover | 164.2K | 389B |
Average Price | 182.44 | 1,916.59 |
Value | 164.2K | 389B |
Indicative Equilibrium Price | 183 | 1,925 |
Indicative Equilibrium Volume | 100 | 9.02K |
Trailing returns across standard periods
Latest headlines on both assets
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →PT Chandra Asri Petrochemical Tbk formerly PT. Tri Polyta Indonesia, Tbk (the Company) was established under the Domestic Capital Investment Law No. 6 year 1968 and Law No. 12 year 1970 by Notarial Deed No. 40 dated November 2, 1984 of Ridwan Suselo, S.H., notary public in Jakarta. The Company is the largest Indonesia producer of polypropyleneresins that are used in the manufacture of a wide range of consumer products.
Read more on TPIA →